Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells
Kenji Otsuka, Atsushi Mitsuhashi, Hisatsugu Goto, Masaki Hanibuchi, Kazuya Koyama, Hirohisa Ogawa, Hirokazu Ogino, Atsuro Saijo, Hiroyuki Kozai, Hiroto Yoneda, Makoto Tobiume, Masatoshi Kishuku, Keisuke Ishizawa, Yasuhiko Nishioka
Topics & Concepts
MedicinePemetrexedMesotheliomaCancer researchAntibodyCisplatinChemotherapyLung cancerMesothelinImmunologyPathologyInternal medicineImmune cells in cancerOccupational and environmental lung diseasesCancer Immunotherapy and Biomarkers